paper with Introduction, Significance of Problem, Theoretical/Conceptual

paper with Introduction, Significance of Problem, Theoretical/Conceptual Framework, Search Strategy, Review of Literature, Proposed Solution, Evaluation/Implementation, Conclusion about patients age between 18-90 undergoing Peritoneal dialysis (p) use of polyhexanide, mupirocin, and the absence of exit site dressing (I) compared to chloral-prep, gentamicin, and covering the site with a sterile gauze dressing (c ) to reduce the exit site infection and peritonitis (o) REFERENCES. Boudville, N., Johnson, D. W., Zhao, J., Bieber, B. A., Pisoni, R. L., Piraino, B., Bernardini, J., Nessim, S. J., Ito, Y., Woodrow, G., Brown, F., Collins, J., Kanjanabuch, T., Szeto, C. C., & Perl, J. (2018). Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study. Nephrology, dialysis, transplantation European Renal Association, 34(12), 2118-2126. https://doi.org/10.1093/ndt/gfy204 Bieber, S., & Mehrotra, R. (2019). Peritoneal dialysis access associated infections. Advances in Chronic Kidney Disease, 26(1), 23-29. https://doi.org/10.1053/j.ackd.2018.09.002 Cullen, L., Hanrahan, K., Edmonds, S. W., Reisinger, H. S., & Wagner, M. (2022). Iowa implementation for sustainability framework. Implementation Science, 17(1), 1-20. https://doi.org/10.1186/s13012-021-01157-5 Einbinder, Y., Cohen-Hagai, K., Shitrit, P. et al. ISPD guideline-driven retraining, exit site care and decreased peritonitis: a single-center experience in Israel. Int Urol Nephrol 51, 723-727 (2019). https://doi.org/10.1007/s11255-019-02100-w GoÅ‚embiewska, E., Ciechanowski, K. Repeat exit site infection in peritoneal dialysis patient with polycythemia vera – a case report. BMC Infect Dis 21, 624 (2021). https://doi.org/10.1186/s12879-021-06342-x Nochaiwong, S., Ruengorn, C., Noppakun, K. et al. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol. Trials 20, 754 (2019). https://doi.org/10.1186/s13063-019-3953-8 Obata, Y., Murashima, M., Toda, N., Yamamoto, S., Tsujimoto, Y., Tsujimoto, Y., … & Nakamoto, H. (2020). Topical application of mupirocin to exit sites in patients on peritoneal dialysis: a systematic review and meta-analysis of randomized controlled trials. Renal Replacement Therapy, 6, 1-10. https://doi.org/10.1186/s41100-020-00261-4 Perl, J., Fuller, D. S., Bieber, B. A., Boudville, N., Kanjanabuch, T., Ito, Y., … & Johnson, D. W. (2020). Peritoneal dialysis-related infection rates and outcomes: results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). American Journal of Kidney Diseases, 76(1), 42-53. https://doi.org/10.1053/j.ajkd.2019.09.016 Piraino, B. M. (2019). Putting peritoneal dialysis catheter infections into perspective. American Journal of Kidney Diseases, 74(5),

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."